Trial intelligence / Profile preview

Gymnema Sylvestre in Metabolic Syndrome

NCT02370121Phase 2Completed

Sponsor
Universidad de Guadalajara
Start
Feb 2013
Primary completion
Dec 2014
Modality
Small Molecules
01

Overview

Phase 2, randomised, double-blind trial of gymnema sylvestre in metabolic syndrome, sponsored by Universidad de Guadalajara. Started Feb 2013; status: completed.

02

Drugs

gymnema sylvestre
03

Conditions

metabolic syndrome

Beyond the preview

Go deeper on NCT02370121.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02370121.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call